FNY Partners Fund’s Insmed INSM Stock Holding History

FNY Partners Fund’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,000	Closed	-$17K	–	835
2017 Q1	$17K	Buy	+1,000	New	+$15.4K	﹤0.01%	991

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

FNY Partners Fund's INSM Position: Q2 2017 in Review

FNY Partners Fund sold out of Insmed (INSM) in Q2 2017, closing a stake of 1,000 shares — an estimated $17K sold.

FNY Partners Fund first reported a position in INSM in Q1 2017 and held it in 1 quarter. The position peaked at $17K in Q1 2017. 114 funds tracked by Wall St. Rank hold INSM as of Q2 2017.

FNY Partners Fund reported no remaining Insmed position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 1,000 Insmed shares in Q2 2017, an estimated $17K.
FNY Partners Fund first reported a position in Insmed in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Insmed position peaked at $17K in Q1 2017.
114 funds tracked by Wall St. Rank held Insmed as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.